FG
UTHR icon

Formula Growth’s United Therapeutics UTHR Stock Holding History

Formula Growth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Sell
5,334
-22
-0.4% -$12.4K 1.02% 32
2026
Q1 		$3.18M Sell
5,356
-258
-5% -$128K 1.43% 15
2025
Q4 		$2.74M Sell
5,614
-936
-14% -$436K 1.05% 30
2025
Q3 		$2.75M Sell
6,550
-1,687
-20% -$567K 0.98% 45
2025
Q2 		$2.37M Sell
8,237
-146
-2% -$43.6K 0.89% 43
2025
Q1 		$2.58M Buy
+8,383
New +$2.87M 1.05% 40

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Formula Growth's UTHR Position: Q2 2026 in Review

Formula Growth reduced its United Therapeutics (UTHR) stake by 0.41% in Q2 2026, selling an estimated $12.4K and leaving 5,334 shares worth $2.89M. The position accounts for 1.02% of the portfolio, ranked #32.

Formula Growth first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.18M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Formula Growth held 5,334 shares of United Therapeutics worth $2.89M as of Q2 2026.
  • Formula Growth sold 22 United Therapeutics shares in Q2 2026, an estimated $12.4K.
  • United Therapeutics made up 1.02% of Formula Growth's portfolio in Q2 2026, its #32 holding.
  • Formula Growth first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Formula Growth's United Therapeutics position peaked at $3.18M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.